Device Devices

Hemocue Hb 801 Analyzer

Payments companies reported to CMS as associated with Hemocue Hb 801 Analyzer. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$295associated payments (2023-2025)

16clinicians with associated payments

1company reporting

By year

2025 $295

Payments reported as associated with Hemocue Hb 801 Analyzer, per program year, as reported to CMS.

Who makes it

Radiometer America, INC $295 associated with Hemocue Hb 801 Analyzer (2023-2025)

Specialties most often involved

Nephrology (Internal Medicine) $129

Family $92.10

Nurse Practitioner $55.27

Acute Care (Nurse Practitioner) $18.43

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Hemocue Hb 801 Analyzer

These are the largest totals companies reported as associated with Hemocue Hb 801 Analyzer. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Paula Elliott	Louisville, KY	Nurse Practitioner	$18.43
Nidhi More	Louisville, KY	Acute Care (Nurse Practitioner)	$18.43
Jamie Baker	Madison, IN	Family	$18.42
Susannah Ward	Louisville, KY	Family	$18.42
Amanda Bierman	Louisville, KY	Nurse Practitioner	$18.42
Raza Ali	Louisville, KY	Nephrology (Internal Medicine)	$18.42
Brandi Ragsdale	New Albany, IN	Family	$18.42
Bhagwan Bhimani	Louisville, KY	Nephrology (Internal Medicine)	$18.42
Anjana Easwar	Louisville, KY	Nephrology (Internal Medicine)	$18.42
Laura Noel	Louisville, KY	Nurse Practitioner	$18.42

Prescribed Hemocue Hb 801 Analyzer?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.